Drug Pricing

Study: GLP‑1 Use Soared and Shifted Costs From Patients to Insurers and Taxpayers

A July study shows rapid uptake drove big jumps in total spending even as patient out‑of‑pocket payments fell, creating fresh questions about who pays for long‑term use.